Beginning in August 2013, the Federal Open Payments Law (also known as the Physician Payment Sunshine Act) requires pharmaceutical and medical device/supply companies to report to Centers for Medicare & Medicaid Services both direct and indirect transfers of value to certain providers and teaching hospitals. See the Office of Compliance & Risk Assurance Open Payments Law Fact Sheet for guidance and more information on this important federal law.